Altre lingue Healios K.K.

Azioni

4593

JP3835100003

Tempo differito Japan Exchange Altri mercati azionari 08:00:00 02/05/2024			Variaz. 5gg	Var. 1 gen.
149 ^JPY	+0,68%		-2,61%	-9,70%

09/04	Healios K.K. stipula un accordo di ricerca congiunta con AND Medical Group	CI
03/04	Healios K.K. (TSE:4593) ha completato l'acquisizione di sostanzialmente tutte le attività di Abt Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA e ReGenesys, LLC.	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Healios Partners with AND Medical Group; Set to Receive Upfront Payment of 60 Million Yen	10/04
Healios K.K. Enters into Joint Research Agreement with AND Medical Group	09/04
Healios Concludes Purchase of Athersys Assets, Becoming Sole Owner of MultiStem IP	04/04
Healios K.K. completed the acquisition of Substantially all assets of Abt Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA and ReGenesys, LLC .	03/04
Japanese Shares Hit Fresh 52-Week Peak Ahead of Inflation Data	26/02
Healios Proposes Reduction of Capital Stock, Reserves, Surplus Appropriation	26/02
Healios K.K. announced that it has received ¥2.2600715 billion in funding	09/02
Healios K.K. and ProcellCure Inc. Announce Start of ARDS Clinical Trial in Japan	02/02
Healios K.K. announced that it expects to receive ¥2.2600715 billion in funding	25/01
Healios and ProcellCure Initiate Clinical Trial for ARDS Treatment	18/01
Japanese Shares Finish Lower After Key Economic Data	18/01
Healios K.K. and Its Wholly Owned Subsidiary ProcellCure Inc. Announce Submission of ARDS Clinical Trial Notification in Japan	18/01
Healios' Ischemic Stroke Trial Data Published in JAMA Neurology Journal	18/01
Healios Secures LOI on Joint Research with AND	17/01
Healios K.K. AND Medical Group Enter into A Letter of Intent for A Basic Agreement for Joint Research	16/01
Healios Steps In as Primary Bidder and Lender for Athersys’s Asset Sale Amidst Bankruptcy	10/01
Healios K.K. entered into an asset purchase agreement to acquire Substantially all assets of ABT Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA and ReGenesys, LLC for $2.8 million.	05/01
Healios, Nobelpharma in Talks for Stem Cell Therapy Alliance for ARDS	28/12
Healios Invests in Arktus Therapeutics at Undisclosed Amount	26/12
Healios K.K. (TSE : 4593) agreed to acquire an unknown minority stake in Arktus Therapeutics Co., Ltd.	22/12

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Healios K.K.

Azioni

4593

JP3835100003

Altre lingue

Filtri